0001213900-20-012640.txt : 20200515 0001213900-20-012640.hdr.sgml : 20200515 20200515164448 ACCESSION NUMBER: 0001213900-20-012640 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 EFFECTIVENESS DATE: 20200515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kitov Pharma Ltd. CENTRAL INDEX KEY: 0001614744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367118 FILM NUMBER: 20886196 BUSINESS ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 BUSINESS PHONE: 97239333121 MAIL ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 FORMER COMPANY: FORMER CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd. DATE OF NAME CHANGE: 20140724 D 1 primary_doc.xml X0708 D LIVE 0001614744 Kitov Pharma Ltd. ONE AZRIELI CENTER ROUND BUILDING TEL AVIV L3 ISRAEL 6701101 97239333121 ISRAEL Mainrom Line Logistics Ltd. Kitov Pharmaceuticals Holdings Ltd. Other Limited company true Isaac Israel One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Executive Officer and Director of the Issuer Eric Rowinsky One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director and Chairman of the Board of Directors of the Issuer Simcha Rock One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director of the Issuer Steven Steinberg One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ido Agmon One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ran Tzror One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Revital Stern-Raff One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Gil Ben-Menachem One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Vice President of Business Development of the Issuer Hadas Reuveni One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer VP R&D of the Issuer Gil Efron One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Deputy CEO and Chief Financial Officer of the Issuer Bertrand Liang One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Chief Medical Officer of the Issuer Michael Schickler One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Head of Clinical Operations of the Issuer Pharmaceuticals Decline to Disclose 06b false 2020-05-06 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA NJ NEW JERSEY NY NEW YORK false 10000001 10000001 0 Represents the aggregate amount received from investors in connection with Issuer's registered offering of ADSs and concurrent private placement of warrants, respectively, which were issued jointly to investors for a single purchase price. false 3 700000 true 0 Represents 7% commission of gross proceeds from investors for sale of ADSs in the registered offering and concurrent private placement of warrants. We also paid or reimbursed expenses of $62,900 and issued unregistered warrants to purchase up to 1,750,000 0 false Kitov Pharma Ltd. /s/ Gil Efron Gil Efron Deputy CEO and Chief Financial Officer 2020-05-15